Cardima, Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	33
ISBN Number	not applicable
Product Code	GMD04765

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Cardima, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Industry Outlook Cardiovascular Devices
3 Major Products and Services
3.1 Overview
4 Key Employees
5 Locations And Subsidiaries
5.1 Head Office
6 Recent Developments
6.1 Corporate Communications
- 6.1.1 Mar 04, 2008: Cardima Appoints SAB Member
- 6.1.2 Feb 22, 2008: Cardima Appoints SAB Member
- 6.1.3 Nov 30, 2007: Cardima Appoints Chief Medical Officer
- 6.1.4 Nov 30, 2007: Cardima Chief Medical Officer Resigns
6.2 Product News
- 6.2.1 Jun 30, 2008: Cardima Receives Chinese SFDA Approval To Market The INTELLITEMP Energy Management Device In The People's Republic Of China
- 6.2.2 Oct 11, 2007: Cardima Announces Patent For INTELLITEMP Energy Management Device
- 6.2.3 Jun 15, 2005: Cardima Inc. Meets With FDA Regarding Revelation TX PMA
- 6.2.4 May 28, 2004: Cardima Receives Non-Approvable Letter From FDA For REVELATION Tx
- 6.2.5 Mar 16, 2004: Cardima Reports On First Clinical Use Of Its INTELLITEMP Radio Frequency Energy Management Device For Pulmonary Vein Isolation
- 6.2.6 Jul 10, 2003: Cardima Receives Approval To Sell New Configuration Microcatheter In Europe; REVELATION Helix STX Extends Treatment Range For Pulmonary Vein Therapeutic Product Line
- 6.2.7 Jul 07, 2003: Revelation Tx Microcatheter Maze Procedure Successfully Treats Paroxysmal AF
- 6.2.8 Nov 05, 2002: Cardima REVELATION Tx Granted Expedited Review By The FDA
- 6.2.9 Apr 03, 2001: FDA Allows Modular PMA Filing For The Revelation Tx System; Cardima Files First Module Of Premarket Approval Application
- 6.2.10 Dec 04, 1998: Cardima Receives Approval For The Revelation Tx To Treat Atrial Fibrillation In The European Union
6.3 Product Approvals
- 6.3.1 Jun 30, 2008: Cardima Receives Chinese SFDA Approval To Market The INTELLITEMP Energy Management Device In The People's Republic Of China
- 6.3.2 Jul 10, 2003: Cardima Receives Approval To Sell New Configuration Microcatheter In Europe; REVELATION Helix STX Extends Treatment Range For Pulmonary Vein Therapeutic Product Line
- 6.3.3 Dec 04, 1998: Cardima Receives Approval For The Revelation Tx To Treat Atrial Fibrillation In The European Union
6.4 Clinical Trials
- 6.4.1 Mar 16, 2004: Cardima Reports On First Clinical Use Of Its INTELLITEMP Radio Frequency Energy Management Device For Pulmonary Vein Isolation
- 6.4.2 Jul 07, 2003: Revelation Tx Microcatheter Maze Procedure Successfully Treats Paroxysmal AF
6.5 Other Significant Developments
- 6.5.1 May 29, 2008: Cardima Signs Distribution Relationship With Dot Medical
7 Cardima, Inc. Pipeline Products
7.1 Cardima, Inc. Product Pipeline Analysis
- 7.1.1 Cardima, Inc. Pipeline Products By Equipment Type
- 7.1.2 Cardima, Inc. Pipeline Products By Development Stage
- 7.1.3 Cardima, Inc. Pipeline Products By Therapy Area
- 7.1.4 Cardima, Inc. Pipeline Products By Clinical Trials
- 7.1.5 Cardima, Inc. Pipeline Products By News Summary
7.2 REVELATION Tx
- 7.2.1 Product Description
- 7.2.2 Product Status
- 7.2.3 Clinical Trials
- 7.2.4 Product Milestone
7.3 Therastream
- 7.3.1 Product Description
- 7.3.2 Product Status
- 7.3.3 Clinical Trials
7.4 Revelation Helix STX
- 7.4.1 Product Description
- 7.4.2 Product Status
- 7.4.3 Product Milestone
7.5 Revelation Helix
- 7.5.1 Product Description
- 7.5.2 Product Status
- 7.5.3 Clinical Trials
8 Appendix
8.1 Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Expert Panel Validation
8.2 Contact Us
8.3 About Global Markets Direct
8.4 Disclaimer
1 List of Tables
Table 1: Cardima, Inc.,Key Facts
Table 2: Cardima, Inc., Key Employees,
Table 3: Cardima, Inc. Pipeline Products by Equipment Type
Table 4: Cardima, Inc. Pipeline Products By Development Stage
Table 5: Cardima, Inc. Pipeline Products By Therapy Area
Table 6: Cardima, Inc. Pipeline Products By Clinical Trials
Table 7: Cardima, Inc. Pipeline Products By News Summaries
1.2 List of Figures
Figure 1: Cardima, Inc. Pipeline Products By Development Stage
Figure 2: Cardima, Inc. Pipeline Products By News Summary
Figure 3: Global Markets Direct Methodology